Key terms
About AKYA
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AKYA news
Apr 09
7:06am ET
Piper Sandler Keeps Their Buy Rating on Akoya Biosciences (AKYA)
Apr 05
8:03am ET
Akoya Biosciences showcases spatial biology 2.0 solutions at AACR meeting
Mar 12
6:36am ET
Akoya Biosciences (AKYA) Gets a Buy from Piper Sandler
Mar 06
6:17am ET
Massaro Issues Buy Rating for Akoya Biosciences Amid Strong Financial Performance and Market Growth Potential
Mar 04
4:21pm ET
Akoya Biosciences sees operating cash flow breakeven by year end
Mar 04
4:20pm ET
Akoya Biosciences reports Q4 EPS (22c), consensus (28c)
Jan 18
8:07am ET
Akoya Biosciences’ PhenoCycler-Fusion platform used by QSBC
Jan 10
8:05am ET
Akoya Biosciences announces establishment of Scientific Advisory Board
No recent press releases are available for AKYA
AKYA Financials
Key terms
Ad Feedback
AKYA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AKYA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range